MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
about
Multiple Targets of Salicylic Acid and Its Derivatives in Plants and AnimalsThe Toll of Vascular Insufficiency: Implications for the Management of Peripheral Arterial DiseaseDAMPs from Cell Death to New LifeStress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory primingDAMPs, MAMPs, and NAMPs in plant innate immunityTrial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapyAspirin's Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory ResponsesAnemia of Inflammation: A Review.Ethanol, TLR3, and TLR4 Agonists Have Unique Innate Immune Responses in Neuron-Like SH-SY5Y and Microglia-Like BV2An ongoing search for potential targets and therapies for lethal sepsisActivation of Plant Innate Immunity by Extracellular High Mobility Group Box 3 and Its Inhibition by Salicylic Acid.Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation.Serum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE ReceptorsHigh Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger MoleculeHematopoietic stem and multipotent progenitor cells produce IL-17, IL-21 and other cytokines in response to TLR signals associated with late apoptotic products and augment memory Th17 and Tc17 cells in the bone marrow of normal and lupus miceHMGB1 mediates anemia of inflammation in murine sepsis survivors.The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome.HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activationB1a cells play a pathogenic role in the development of autoimmune arthritis.Treatment with anti-HMGB1 monoclonal antibody does not affect lupus nephritis in MRL/lpr mice.EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation.Blocking Notch signal in myeloid cells alleviates hepatic ischemia reperfusion injury by repressing the activation of NF-κB through CYLDAnnexin A5 increases survival in murine sepsis model by inhibiting HMGB1-mediated pro-inflammation and coagulation.HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia.Effect of endotoxemia in mice genetically deficient in cystathionine-γ-lyase, cystathionine-β-synthase or 3-mercaptopyruvate sulfurtransferase.Novel strategies for targeting innate immune responses to influenza.Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01.The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes.Lupus erythematosus revisited.Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?Novel perspectives on non-canonical inflammasome activation.HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarminsInnate Immune Regulations and Liver Ischemia-Reperfusion Injury.HMGB1 is a promising therapeutic target for acute liver failure.The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation.Engineering of a self-adjuvanted iTEP-delivered CTL vaccine.Leucine-rich repeat 2 of human Toll-like receptor 4 contains the binding site for inhibitory monoclonal antibodies.Secreted tryptophanyl-tRNA synthetase as a primary defence system against infection.
P2860
Q26745979-A0A392A3-7961-4E73-A241-533E3739C606Q26753079-5BF0722A-E7EB-44E0-B0CD-052DF3C96116Q26782785-41479BA7-1F73-49F6-8E3D-EDD1C1296DF1Q27013816-E1ABC05B-7B71-4EC8-BD72-ED772C9182C3Q28066924-7B913475-2EC3-4BAC-AEFB-056A04AC861FQ28067939-06D4C6BB-D6F8-4FE5-85A3-5CBD971855C0Q28611255-6C742637-FBA9-4C63-A02C-417CC4F41C96Q30235957-E3ADA18F-4388-4961-A37A-6BCA3348D312Q33610059-B07775FE-6ED7-441C-AAA2-6D91BEADD0C6Q35930160-DD104E65-2BC9-427F-A30F-16A638E11B51Q35967360-E0EFD99C-6DB0-40C8-A49A-F417C6EA3C37Q36145679-76B5603A-DC9C-43C2-8DDC-48087FC6A13DQ36167046-F2969536-26E3-43FC-BF86-CEE237394288Q36322388-C0919B2C-E473-4BCA-BC6C-5902B6C099EAQ36421539-967BFAA0-5214-40DC-A053-8BECB2CFD9C9Q36758021-623470A7-55B7-4610-A01C-9D4A01EE951CQ36814026-872B51E0-3D8A-4C7E-8DF0-8BF3AC4EC584Q36935091-AEC6173C-C35D-425D-8F9A-E80C3D5ACD45Q36992432-95A3C250-7737-42BA-8E6F-3D766E471293Q37021812-763178F9-B281-43B2-A2C5-6E0410D6E213Q37190057-88124EE0-1EB6-4428-A7E2-304D0026F7F0Q37217002-232CE7FE-2704-45D4-AE06-6FD78D12FF0CQ37269308-D33DA6BE-A128-4925-9431-F3461BB3395AQ37294034-3B1673AC-8A68-4677-BFF7-9533C63FAE29Q37353931-1988298F-9A8B-4837-B4CD-D5D465F6159AQ37381541-A7A7B4CC-E647-49B2-9495-147D7256B2C6Q37426673-DA0D4532-B423-478A-AA9D-1BBAF9D8BE8AQ37445698-ED701111-0923-468F-9711-6191281E5E35Q37519354-70390489-23B7-4697-8690-C74706915EE0Q37560287-21FBC397-5BBC-4641-ACB7-C7C235AA0AC3Q38659241-F2AA82B2-5041-4EDB-BF84-F2427F13BFE7Q38753644-85AC50DA-8541-4B14-93E7-B84AE456ED74Q38912292-36478E12-ECF5-4FF9-8206-10EAE2148958Q38939435-642303EF-DE00-4E88-AA05-2625290DD52EQ39012727-9BD1CC25-2167-4696-9091-E2FF29CFF0DFQ39402112-8B1F01D1-1B88-4604-A798-94736A79B301Q40229508-7B4B4D7E-0805-4F4D-9EE4-02A5C57B6A34Q40248942-CA40ACE4-B508-407F-8305-9BA8E8614461Q40280609-83376500-F6D6-4540-A658-1FFB455F2707Q40504254-CABFA4D1-7F7E-48EE-A0BC-CEDA5E620B34
P2860
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@ast
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@en
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@nl
type
label
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@ast
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@en
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@nl
prefLabel
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@ast
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@en
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@nl
P2093
P2860
P50
P356
P1476
MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
@en
P2093
Ahmed A Ragab
Csaba Szabo
Daniel J Antoine
Doug T Golenbock
Helena E Harris
Jesse Roth
Jianhua Li
Jianmin Meng
P2860
P356
10.1084/JEM.20141318
P407
P577
2015-01-05T00:00:00Z